Literature DB >> 2504921

Design of potential anti-HIV agents. 1. Mannosidase inhibitors.

D A Winkler1, G Holan.   

Abstract

A molecular orbital and molecular graphics study of 12 substrates, inhibitors, reaction intermediates, and substrate analogues of alpha-mannosidase was undertaken. The results indicated that potent inhibitors must be good topographical analogues of the mannopyranosyl cation, an intermediate in the reaction catalyzed by the enzyme. Enzyme recognition and strong binding by the inhibitors requires that they contain, as part of their structure, electronegative atoms which are the topographical equivalent of the mannosyl cation C2 and C3 hydroxyl groups and ring heteroatom. The absence of a topographical analogue of the C4 hydroxyl group of the cation appeared to have little effect on the binding and activity of inhibitors. These results have been utilized in the design of potential anti-HIV drugs whose synthesis is now under consideration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504921     DOI: 10.1021/jm00129a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

Review 1.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

2.  Structural basis of the inhibition of Golgi alpha-mannosidase II by mannostatin A and the role of the thiomethyl moiety in ligand-protein interactions.

Authors:  Sameer P Kawatkar; Douglas A Kuntz; Robert J Woods; David R Rose; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2006-06-28       Impact factor: 15.419

3.  Investigations of scope and mechanism of nickel-catalyzed transformations of glycosyl trichloroacetimidates to glycosyl trichloroacetamides and subsequent, atom-economical, one-step conversion to α-urea-glycosides.

Authors:  Matthew J McKay; Nathaniel H Park; Hien M Nguyen
Journal:  Chemistry       Date:  2014-06-06       Impact factor: 5.236

4.  1-(2-Bromo-acet-yl)-3-methyl-2,6-diphenyl-piperidin-4-one.

Authors:  G Aridoss; S Sundaramoorthy; D Velmurugan; K S Park; Y T Jeong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-29

5.  1-Chloro-acetyl-2,6-bis-(3-fluoro-phen-yl)piperidin-4-one.

Authors:  G Aridoss; D Gayathri; D Velmurugan; M S Kim; Yeon Tae Jeong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-25

Review 6.  Chiropractic case reports: a review and bibliometric analysis.

Authors:  Robert J Trager; Jeffery A Dusek
Journal:  Chiropr Man Therap       Date:  2021-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.